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ABSTRACT Molecular mimicry is a recurrent theme in host defense processes. The correlation of functional mimicry with the
structural features of the antibody paratope has been investigated, addressing the consequences of mimicry in host immune
mechanisms. Two anti-mannopyranoside antibodies, 1H7 and 2D10, representing the possible extremes of the recognition spec-
trum with regard to peptide-carbohydrate mimicry were examined. Crystallographic and molecular dynamics simulation ana-
lyses established correlation between the antibody ﬂexibility and the manifestation of mimicry. It was evident that monoclonal
antibody (mAb) 1H7, which has a narrow speciﬁcity in favor of the immunizing antigen, exhibited structural invariance. On the
other hand, the antigen-combining site of 2D10, the mimicry-recognizing antibody, showed substantial divergence in the
complementarity determining region loops. The docking of mannopyranoside within the antibody paratope revealed multiple
modes of binding of the carbohydrate antigen in mAb 2D10 vis a` vis single docking mode in mAb 1H7, which overlapped with
the common monosaccharide binding site deﬁned in anti-carbohydrate antibodies. The presence of additional antigen binding
modes is perhaps reﬂective of the utilization of conformational ﬂexibility in molecular mimicry. A relatively broader recognition
repertoire—attributable to paratope ﬂexibility—may facilitate the recognition of altered antigens of invading pathogens while the
antibodies with narrow recognition speciﬁcity maintain the ﬁdelity of the response.
INTRODUCTION
The hallmark of the acquired immune system is remarkable
specificity in its recognition repertoire that not only counters
the invading pathogens but also ensures self-nonself discrim-
ination. Studies involving various aspects of humoral and
cellular immunity have enormously contributed to our pres-
ent view of the specificity and complexity of molecular recog-
nition. Although resemblance between antigenic determinants
of the invading pathogen and the host may be critical for
entry and manipulation of host cellular mechanisms, immune
mechanisms have evolved toward fine discrimination be-
tween molecules which may otherwise appear similar. Molec-
ular mimicry, in essence, is the antithesis of the specificity of
antigen recognition and is the central premise implicated in
the etiology and pathogenesis of autoimmunity (1,2).
Since molecular recognition is mediated by a combination
of weak noncovalent interactions, structural similarity be-
tween antigens has often been thought to be the basis of
molecular mimicry. However, functional correlation without
adequate topological similarity has indeed been demonstrated
(3–5). The emerging dichotomy enforces exploration of other
physicochemical properties of the mimotopes as well as re-
ceptors in describing the basis of mimicry. Delineation of the
molecular mechanisms associated with the recognition of
chemically independent yet mimicking antigens is therefore
crucial for a better understanding of mimicry in the immune
response.
Mimicry between the carbohydrate moiety, methyl-a-D-
mannopyranoside, and the Tyr-Pro-Tyr motif containing pep-
tides has been extensively addressed in this laboratory using
concanavalin A as a common receptor (6–9). The carbohy-
drate antigen and its mimicking 12-mer peptide (DVFYPY-
PYASGS) were established to be equivalent in terms of the
physiological responses generated against either of them
(10,11). Functional equivalence between the antigens was
observed not only in terms of cross-reactivity but also during
maturation of the antibody response and generation of immune
memory. Toward molecular depiction of the functional mim-
icry, a panel of monoclonal antibodies (mAbs) was generated
against mannopyranoside (12). Kinetic and thermodynamic
investigations of antigen binding to these mAbs indicated the
possible role of conformational flexibility in the manifesta-
tion of mimicry.
The studies presented here address the immune mecha-
nisms implicated in molecular mimicry. We attempted to
discern the structural properties associated with the mani-
festation of mimicry using a set of independent antibodies
which differed in their ability to recognize a pair of mim-
icking antigens, a carbohydrate and a peptide. Crystallo-
graphic and in silico analyses of the anti-mannopyranoside
antibodies, 1H7 and 2D10, demonstrate the overwhelming
influence of the structural properties of the paratope in mod-
ulating molecular mimicry in the antibody response. It was
revealed that the manifestation of functional mimicry is as-
sociated with flexibility in the antibody paratope and can be
correlated with the differential modes of antigen binding.
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MATERIALS AND METHODS
Generation of mAbs and Fab fragments
The anti-mannopyranoside mAbs used in this study were generated pre-
viously from an immune response against mannopyranoside-keyhole limpet
hemocyanin (12). Purification of the antibodies, 1H7 and 2D10, from ascites
was carried out following a two-step protocol that involved an initial partial
purification with 40% ammonium sulfate fractionation followed by ion
exchange chromatography on a diethylaminoethyl (DEAE) anion exchange
column on high performance liquid chromatography.
Fab fragment was generated by papain digestion of the purified antibody
in 100 mM TrisCl, pH 7.1 with 150 mM NaCl, and purified from the di-
gestion mix by using DEAE anion exchange chromatography. The purity
was checked by sodium dodecylsulfate-polyacrylamide gel electrophoresis,
and the concentration of the Fab was estimated by protein assay (Bio-Rad,
Hercules, CA) by using bovine serum albumin as the standard. The concen-
trated (10 mg/ml) Fab was dialyzed against the crystallization buffer, 50 mM
TrisCl, pH 7.4, and/or 50 mM cacodylate, pH 6.8 with 0.05% sodium azide.
Crystallization and data collection
For crystallization of mAb 1H7, hanging drops containing 3–5 ml of
1H7 Fab and equivalent volume of the precipitant were set up at 25C with
and without 25 molar excess of mannopyranoside. The crystals were
cryoprotected by soaking in mother liquor containing 25% glycerol and flash
frozen. Data were collected on a MAR345dtb image plate (Marresearch,
Norderstedt, Germany) installed on a rotating anode x-ray source (Rigaku,
Tokyo, Japan) operating at 5.0 kW at 120 K and processed and scaled with
AUTOMAR (Marresearch).
Structure determination and reﬁnement
The structure was determined by molecular replacement using AmoRe (13).
Anti-arsonate antibody 36–71 (Protein Data Bank (PDB) ID: 6FAB) was
used as the probe model as the intensity data gave a correlation coefficient of
32.8% and R-factor of 46.3%. The light and heavy chains were defined as L
and H, respectively, in one molecule in the asymmetric unit and as A and B,
respectively, in the other. Subsequent refinement with CNS (14) was con-
ducted by using this model and conventional Rcryst and Rfree (10% of total
reflections) values were monitored (15). Rigid body refinement was first
carried out for the individual Fab molecules, and then the VH, VL, CH, and
CL domains were treated as discrete units followed by iterative positional
refinement. Electron density maps were displayed with the help of program
O (16), and the sequence of antibody 36–71 was slowly changed to that of
mAb 1H7 and water molecules added. The overall quality of the model was
evaluated with PROCHECK (17); 96.7% residues are in the allowed regions
of the Ramachandran plot, 2.5% in the generously allowed and 0.8%, in-
cluding L56N (complementarity determining region (CDR) L2), H102W
(CDRH3), A53A (CDRL2), and B105A (CDRH3), in the disallowed regions.
The structural data, including amplitudes and phases, and the derived
coordinates of the Fab fragment of the mAb 1H7 are deposited at the PDB
(Accession No. 2V7H).
Molecular modeling
For homology modeling of anti-mannopyranoside antibody 2D10, the struc-
ture of anti-digoxin Fab (PDB ID: 1IGI) was used as template; it showed
maximum sequence identity with both heavy and light chains. Since we
were primarily studying the antigen binding site and its interactions with
the ligand, only the variable regions of the antibody were modeled using the
HOMOLOGY module of INSIGHT II (Accelrys, 1998). Subsequently, the
structure of 2D10 Fv was energy minimized in the DISCOVER module of
INSIGHT II with 100 steps of steepest descent minimization followed by
400 steps of conjugate gradient minimization with gradually decreasing
tethering to the backbone of the structure in AMBER force field. The final
model was validated by PROCHECK (17). Of the 230 residues of 2D10, Fv
98% are in the allowed regions of the Ramachandran plot, 1.0% in the
generously allowed and 1.0%, Val-56 (CDR L2) and Tyr-213 (CDR H3), in
the disallowed regions.
Molecular dynamics simulation
All MD simulations of the variable regions of the anti-mannopyranoside
mAbs were carried out using explicit solvent with an 8 A˚ water box beyond
the Fv boundary at 16C and 35C in the SANDER program of the AMBER7
package for the duration of 500 ps and AMBER9 for the 2 ns simulations
(18). To correlate with the previous thermodynamic analyses (12), the ref-
erence temperature for MD simulation was set at 16C. The simulations
were carried out keeping the volume constant with a time step of 2 fs (using
SHAKE) and a cutoff of 8 A˚. This was exclusive of an initial 25 ps equil-
ibration, wherein all atoms were constrained by a harmonic potential, with a
force constant of 5 kcal/mol/A˚.2 Thereafter only the Ca atoms of the frame-
work regions of the two antibodies were tethered keeping all atoms of the
CDR loops free, thus permitting an exhaustive exploration of possible paratope
conformations. Energy variation during the first 100 ps was monitored to
ensure that the structures were optimized. Structure outputs were taken from
the simulation every 0.2 ps, and energy minimization (100 steps of steepest
descent minimization followed by 400 steps of conjugate gradient minimi-
zation in AMBER) and analyses were done for structures output every 10 ps.
The ensemble of structures was visualized and root mean-square deviation
(RMSD) of the Ca atoms of the CDR loops was calculated.
Automated docking of mannopyranoside
and glucopyranoside
The program AUTODOCK3.05 is an automated procedure for predicting
where a ligand binds on the surface of a macromolecule on the basis of the
interaction between the two (19). AUTODOCK3.05 treats the macromolecule
as rigid, whereas the ligand is allowed torsional flexibility. The Lamarckian
genetic algorithm (LGA) is most efficient in searching the conformational
space for the best docking energy (19). As an input, the Fv fragment of the
antibodies were provided to the program with a rectangular box, a grid of
70 points in three dimensions with a spacing of 0.375 A˚ centered at the co-
ordinates of the antigen-combining site, within which the program finds the
binding site. Rigidity of the paratope during docking does not detract from
its validity as multiple conformations of the antibody generated during MD
simulation, for both ‘‘rigid’’ 1H7 Fv (with altered side-chain conformation
of HTyr-106) and the ‘‘flexible’’ mAb 2D10, have been used to carry out
multiple runs of the program.
For either antibody, docking of mannopyranoside and glucopyranoside was
attempted on 11 different structures output every 50 ps during the course of the
MD simulation. The default settings of AUTODOCK3.05 were used, with the
exception of the number of runs, which was set to 100. AUTODOCK3.05
provides a comprehensive view of the available ligand docking sites and
additionally calculates the docking and interaction energies as well as the
theoretical affinity of the interaction of the ligand at each docking position. No
external bias can be applied to steer the selection of the docking sites, except
by exclusion from the grid frame, within the protein. In this study, all docking
options (;15%) that were found to be outside of the antibody paratope were
regarded as nonphysiological and therefore omitted from our analysis.
Analysis of the docking energy of individual docking options was carried out
to evaluate the affinity of mannopyranoside or glucopyranoside.
RESULTS
Antigen-free states of the
anti-mannopyranoside mAbs
From the panel of anti-mannopyranoside mAbs, two anti-
bodies, 1H7 and 2D10, which appeared to represent apparent
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extremes of specificity of antigen recognition, were analyzed
at the structural level. Although mAb 1H7 was highly spe-
cific to the mannopyranoside immunogen, mAb 2D10 rec-
ognized both the carbohydrate and its mimicking peptide
with similar affinities (12). Fab was generated for the anti-
bodies, and crystallization attempts included both the antigen-
free and antigen-bound states.
Crystals of 1H7 Fab could be obtained in the presence of
mannopyranoside. The structure was determined by molec-
ular replacement at 2.8 A˚ resolution. Data collection and
refinement statistics are provided in Table 1. Analysis of the
structures of the two Fab molecules, AB and LH, in the
asymmetric unit (Fig. 1 A) revealed that five of the six CDRs
could be assigned to known classes of canonical structures
(20,21): L1:2, L2:1, L3:1, H1:1, and H2:2. Although the
elbow angles in the two molecules were within the reported
range (127–227 (22)), they differed significantly between
the two molecules; in the case of AB, it was 163, whereas in
LH, it equaled 176 (Fig. 1 B). Although residues of the CDRs
in AB interact with both chains (L9 and H9), the paratope of
LH primarily interacts with only the light chain of the symmetry-
related molecule (A9; Fig. 1 C).
Despite large differences in the elbow angles and the nature
of interacting residues of the symmetry-related molecule, the
two molecules in the asymmetric unit do not differ in their
CDR conformations. The orientations of most of the side
chains do not show major variation, such that the surface
topology of the antigen-combining sites of AB and LH are
similar (Fig. 1 C). The superimposition of the Ca atoms of
the CDR loops is depicted in Fig. 1 D. The RMSD for each
of the six CDRs ranged from a minimum of 0.4 A˚ to a
maximum of 0.7 A˚ (in the case of CDR H3). In addition, the
average B-factors of the antigen binding CDR loops did not
exhibit significant differences vis a` vis the framework region
in both AB and LH. Thus, structural similarity in the paratope
of AB and LHwas observed despite differences in their elbow
angles and packing environments. It therefore appears that
the absence of conformational and topological difference in
the antigen binding site of the two molecules may be a re-
flection of the inherent ‘‘rigidity’’ of the antibody paratope.
Although the crystallization of the 1H7 Fab was in the
presence of 25-fold molar excess of the mannopyranoside,
the antibody crystallized, excluding the antigen. No electron
density was decipherable for the carbohydrate ligand in
either of the two molecules in the asymmetric unit even after
adequate refinement of the crystal structure. Analysis of
several carbohydrate-antibody complex structures indicated
a common binding site for a monosaccharide moiety (Fig.
2 A; 23–29). An exhaustive search for electron density in and
around the proposed common monosaccharide binding site
confirmed that the 1H7 Fab was in the native unliganded
state in both AB and LH. Instead, it was found that the side
chain of antibody heavy-chain Tyr-106 (HTyr-106 and BTyr-
106) occupied the common monosaccharide binding site
(Fig. 2 B). Steric hindrance due to the bulky phenyl side
chain probably prevented the binding of the mannopyrano-
side ligand during crystallization. The orientations of the side
chains of HTyr-106 and BTyr-106 were apparently locked
because of multiple van der Waals contacts and hydrogen
bonds within the paratope and with the symmetry-related
molecule (Fig. 2 B). Additionally, water molecules present in
the vicinity also stabilize the orientation of the tyrosine side
chain. Thus, crystal packing appears to secure the orientation
of HTyr-106 and BTyr-106 such that 1H7 Fab crystallizes
in the unliganded state despite much molar excess of
mannopyranoside in the crystallization setup.
Native 1H7 Fab in the absence of any antigen also crys-
tallized in the P21 space group with unit cell dimensions
almost identical to those of the Fab cocrystallized in the
presence of mannopyranoside (data not shown). The struc-
ture was determined and refined at 2.8 A˚ resolution and was
found to be identical to the structure of 1H7 Fab crystallized
in the presence of the antigen. The common orientation of
HTyr-106 and BTyr-106 in the two structures reinforced the
interpretations regarding the antigen-free state of the previ-
ous structure.
Structural investigations of the mimicry-recognizing mAb
2D10 by x-ray crystallography were also attempted. How-
ever, crystallization trials with either the Fab fragment or
the whole immunoglobulin G molecule of mAb 2D10 were
unsuccessful, probably due to the existence of multiple con-
formational states, in dynamic equilibrium because of the
flexible nature of the antibody paratope. Alternatively,
TABLE 1 X-ray data collection, structure reﬁnement, and
validation statistics for 1H7 Fab crystal in the presence of the
cocrystallization ligand mannopyranoside
Parameter 1H7 Fab
Space group P21
No. of molecules in asymmetric unit 2
Cell constants (A˚)
a 40.0
b 79.7
c 132.3
b 90.7
Resolution (A˚) 50.0–2.8
Completeness (%) 95.9 (94.4)
No. of observed reflections 64,600
No. of unique reflections 19,865
Multiplicity 3.25
Average ÆIæ/ÆsigIæ 7.3 (1.2)
Rmerge (%) 9.8
Matthews coefficient (A˚3/Dalton) 2.2
Rfree (%) 26.7
Rcryst (%) 24.2
No. of solvent molecules 106
RMSD bond length 0.01
RMSD bond angle 1.76
Ramachandran plot
Residues in allowed region 96.7%
Residues in generously allowed region 2.5%
Residues in disallowed region 0.8%
Values in parentheses correspond to the highest resolution shell.
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homology-based modeling of the Fv fragment of mAb 2D10
was carried out as the variable regions of the heavy and light
chains of the antibody had been previously sequenced (12).
Homology searches indicated that the heavy chain of mAb
2D10 shared 94.9% identity with an antibody known to
cross-react between myosin and streptococcal antigens (30)
and 93.2% identity with antibodies found in systemic lupus
erythematosus, an autoimmune disorder (31). The light chain
FIGURE 1 Two molecules in the
asymmetric unit of 1H7 Fab crystals.
(A) Secondary structure elements of the
mAb 1H7 Fab molecules, AB and LH.
b-sheets are depicted as ribbons in yel-
low anda-helices as cylinders in red. (B)
Superimposition of the backbone of var-
iable regions of the light and heavy chains
of AB and LH to highlight the difference
in the elbow angles of the two molecules
of the asymmetric unit. (C) Connolly sur-
faces of AB and LH colored according to
hydropathy emphasizing the similarity of
surface topology of the two molecules of
the asymmetric unit in the crystalline state.
Overlaid on the surface are the residues of
the symmetry-related molecules, in green,
that interact (within 4 A˚) with the CDR
loops of AB and LH. (D) Ribbon repre-
sentation of the six CDR loops (L1, L2,
L3, H1, H2, and H3) showing the absence
of structural variation between the two
molecules, AB and LH. The backbone
Ca atoms of the framework regions of
the two molecules were superimposed to
highlight the differences, if any, in the
conformations of the CDR loops.
FIGURE 2 Common monosaccharide binding
site in anti-carbohydrate antibodies. (A) Stereo-
scopic representation of the monosaccharide unit
interacting at the common site is depicted in the
context of the CDR loops of the structure of mAb
1H7. Analysis of the structures of different anti-
carbohydrate antibodies in complex with oligosac-
charides revealed that at least one monosaccharide
unit of their respective carbohydrate ligands par-
tially overlaps at a common site. The antibodies
have been superimposed using the backbone of
both light and heavy-chain framework regions. The
sugars are colored according to the legend that lists
the PDB accession code of their carbohydrate-
antibody structures. (B) Environment of heavy-
chain Tyr-106 of the two molecules, AB and LH,
with interacting residues within 4 A˚. Residues of
the light and heavy chain of the same molecule are
shown in light and dark blue, respectively, and
those from the symmetrically related molecule are
colored in orange and green, respectively. Water
molecules are depicted as red spheres.
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also shows high homology (99.1% identity) with autoanti-
bodies that recognize mimicry (32). The high degree of sim-
ilarity between the mimicry-recognizing mAb 2D10 and
other antibodies known to be cross-reactive may have im-
plications in the patterns of usage of V, D, and J gene seg-
ments in the context of molecular mimicry.
Model building involved the transfer of coordinates of the
backbone and identical side chains of the Fv region from the
anti-Digoxin (digoxigenin tridigitoxoside) antibody 26-10
(PDB ID: 1IGI) that showed 72% and 94% identity with the
heavy and light chains of mAb 2D10, respectively (Fig. 3 A),
followed by energy minimization and stereochemistry
validation. Fig. 3 B depicts the secondary structure repre-
sentation of 2D10 Fv. The six CDR loops (L1, L2, L3, H1,
H2, and H3) that together form the antigen-combining site
are depicted in Fig. 3 C. Five of the six CDRs could be as-
signed to the known classes of canonical structures (20,21):
L1:4, L2:1, L3:1, H1:1, and H2:2. Interestingly, four of the
five CDR loops of mAbs 1H7 and 2D10 belong to the same
canonical class, whereas L1, which has five-residue insertion
in the case of mAb 2D10, belongs to a different class.
Correlation of molecular mimicry and the
conformational ﬂexibility in the antibody paratope
Kinetic and thermodynamic analyses of binding had sug-
gested that although the mannopyranoside-specific mAb
1H7 may have a predesigned combining site for the carbo-
hydrate antigen, that of mAb 2D10 appeared to undergo
conformational change to bind the peptide mimic as well as
the carbohydrate immunogen (12). One of the approaches to
image the possible conformational flexibility in the binding
site of a receptor/antibody would be to carry out molecular
dynamics (MD) simulation at different temperatures. Such a
simulation done in the presence of solvent is a close ap-
proximation of the natural status of proteins wherein a flex-
ible protein is likely to exist in a dynamic equilibrium of
different conformational states. Toward deciphering the extent
of flexibility present in the antibody paratope, MD simula-
tions of the variable regions of mAbs 1H7 and 2D10 were
carried out. The coordinates of 1H7 Fv were taken from the
crystal structure of native 1H7 Fab, whereas the model of
2D10 Fv was used as the starting structure for the MD
simulation.
To ascertain the degree of conformational variation extant
in the two antibodies, 2 ns MD simulation was carried out at
35C wherein greater mobility would be possible with ref-
erence to simulation at 16C. Fig. 4 shows the comparison of
the antibodies in terms of potential energy variations of the
hydrated Fv molecule and the conformational fluctuations in
the CDR loops across the 2 ns simulations at 16C and 35C.
The energy profiles of the antibodies at the two temperatures
do not seem to be significantly different (Fig. 4 A). However,
the conformations of the CDR loops appear to vary consid-
erably (Fig. 4, B and C). No significant difference is ob-
served in the RMSD of Ca atoms of the six antigen binding
loops of mAb 1H7 Fv at the two temperatures (Table 2 and
Fig. 4 B). On the other hand, in the case of mAb 2D10, the
FIGURE 3 Homology modeling of
2D10 Fv. (A) Sequence alignment of
variable region of light and heavy
chains of 2D10 with 1IGI. The template
for model was selected on the basis of
highest homology with both chains of
the antibody for optimum juxtaposition
of the VL and VH domains. Although
the light chain shows 94% identity, the
heavy chain shares 72% identity. (B)
Secondary structure rendition of the
model of 2D10 Fv with b-sheets
depicted as dark gray ribbons. (C)
Antigen-combining site of mAb 2D10
with the six CDR loops highlighted.
Orientation of the figure (C) is rotated
by 90 with respect to the figure (B).
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average RMSD increased appreciably: from 16C to 35C.
Significant contribution to this variability in RMSD at 35C
in mAb 2D10 arises due to CDR L1, which has a five-residue
insertion vis a` vis mAb 1H7 (Fig. 4 C). Although the extent
of variation of CDR H3, the specificity-defining loop, of 1H7
Fv either at 16C or 35C is comparable, greater RMSD fluc-
tuations and conformational variability is seen in CDR H3 of
mAb 2D10 in comparison with the antibody 1H7 (Table 2
and Fig. 4 C).
Comparative MD simulations carried out for a relatively
shorter duration of 500 ps for each of the conditions provide
inferences consistent with 2 ns runs despite the difference in
the duration of the simulations and initial velocity (Supple-
mentary Material Table 1 and Supplementary Material Fig.
1 A). Although the average RMSD fluctuations show neg-
ligible difference in the case of mAb 1H7 at either of the
temperatures, for mAb 2D10 they vary significantly (Sup-
plementary Material Fig. 1 B), with the difference for CDR
H3, the specificity-defining loop, being exaggerated during
the shorter 500 ps simulations (Supplementary Material
Fig. 1 C).
Thus, the Fv fragments of the anti-carbohydrate antibodies
were subjected to simulations at near physiological temper-
ature (35C) in an attempt to correlate paratope conforma-
tional flexibility with manifestation of mimicry, as suggested
by thermodynamic analyses (12). Evaluation of the RMSD
of Ca atoms of the CDRs was considered to be a good in-
dicator of the degree of conformational divergence in the
structures generated during the MD simulations. The extent
of variation seen in the RMSD of the Ca atoms of the CDRs
of mAb 2D10 vis a` vis mAb 1H7 at 35C reinforces that the
antigen binding site of mAb 2D10 possesses flexibility
whereas that of mAb 1H7 is rigid. This flexibility within the
mAb 2D10 paratope compared to mAb 1H7 seems to be
FIGURE 4 MD simulation to inves-
tigate the extent of conformational
flexibility in the antigen-combining
sites of the anti-mannopyranoside anti-
bodies. (A) Potential energy profile of
1H7 and 2D10 Fv during simulation.
The framework regions of the different
structures were superimposed to high-
light the extent of variation in the CDR
conformations across the simulation.
(B) RMSD of backbone Ca atoms of
the CDR loops during MD simulation
of 1H7 and 2D10 Fv at 16C and 35C,
with all six CDRs together. Maximum
variation in the CDR backbone confor-
mation is seen in the case of 2D10 Fv at
35C. (C) Stereoscopic representation
of the Ca trace (left) and heavy atoms
(right) of the CDRs of the structures
output every 50 ps from the MD sim-
ulation of 1H7 Fv (top) and 2D10 Fv
(bottom) at 35C, superimposed with
respect to the framework region.
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correlated with the intramolecular contacts within the CDRs;
there exist 27 hydrogen bonds within the antigen-combining
site of mAb 1H7 vis a` vis 8 within mAb 2D10.
Conformational states of the antibody paratope
and antigen binding modes
Structural analyses of the molecular complexes of the two
antibodies, 1H7 and 2D10, with the carbohydrate immuno-
gen would enable the understanding of the role of confor-
mational flexibility in their antigen recognition potential. Such
an analysis was accomplished by in silico docking of the
mannopyranoside antigen in the paratope of the two anti-
bodies.
In the crystal structure of 1H7 Fab, the tyrosine side chain
of H106 was found to be occupying the common monosac-
charide binding site—which may be defined as the primary
site—in anti-carbohydrate antibodies (Fig. 2 A). Thus, it can
be envisioned that for mannopyranoside to be docked in the
1H7 antibody paratope guided by the position of the com-
mon binding site, an alternate conformation for the heavy-
chain Tyr-106 side chain needed to be searched. Energy
needed for such a change in the orientation of the side chain
is likely to be negligible and was reflected in the thermo-
dynamic analyses (12). Furthermore, to validate the alternate
heavy-chain Tyr-106 rotamer, MD simulation of the struc-
ture was carried out, at 35C, and the HTyr-106 side chain
was found to be stable in the alternate orientation during the
500 ps simulation.
To determine the possible modes of binding of the carbo-
hydrate immunogen, docking by AUTODOCK3.05 (19) of
the mannopyranoside antigen on 1H7 Fv with the altered
conformation for heavy-chain Tyr-106 was attempted.
Multiple structures output from the MD simulation every
50 ps were used for the docking analysis. Fig. 5 A depicts the
superimposition of the individual docking options output
with the different structures of 1H7 Fv. There appears to be a
single mannopyranoside docking site that dominates the anti-
body paratope which also overlaps with the proposed common
monosaccharide binding site. Although, the relative orien-
tations of the carbohydrate ligand at this dominant site dif-
fer, the docking energies of the various options are within a
narrow range. Interestingly, the AUTODOCK3.05 analysis
involving mannopyranoside and the 1H7 with the crystallo-
graphically obtained orientation of the heavy-chain Tyr-106
did not show similar binding of the carbohydrate antigen.
AUTODOCK3.05 was also used for docking mannopyr-
anoside in the paratope of antibody 2D10 toward analyzing
the possible sites and modes of interaction with the carbo-
hydrate immunogen. It was hypothesized that the flexibility
in the binding site may be utilized for the recognition of
diverse ligands with similar affinity. Docking parameters,
including grid size selected for the conformational space
exploration, were identical to those used in the case of mAb
1H7. The docking options from the individual runs of
AUTODOCK3.05 are depicted in Fig. 5 A along with their
respective antibody paratopes. Consistent with expectations,
the mannopyranoside ligand is docked at multiple locations
within the antigen binding site. However, one of the domi-
nant sites overlaps with the common monosaccharide binding
TABLE 2 Average ﬂuctuation in RMSD of Ca atoms of the CDR
loops of the anti-mannopyranoside antibodies during MD
simulations for a duration of 2 ns
Average RMSD Fluctuations (A˚)
All CDRs CDR H3
mAb 1H7 mAb 2D10 mAb 1H7 mAb 2D10
16C 1.21 (60.07) 1.17 (60.12) 1.59 (60.19) 1.48 (60.25)
35C 1.16 (60.11) 1.41 (60.38) 1.84 (60.36) 2.09 (60.57)
Structures output every 10 ps were superimposed with respect to the frame-
work region. Values in parentheses represent the standard deviation.
FIGURE 5 Stereoscopic representa-
tion of the docking of monosaccharides
within the paratope of the antibodies,
1H7 and 2D10. Antigen-combining site
of mAb 1H7 (left) and mAb 2D10
(right) with the various docking options
of (A) mannopyranoside and (B) gluco-
pyranoside generated during the in-
dividual runs of AUTODOCK3.05.
Structures that were output every 50
ps during the 500 ps MD simulation at
35C were selected for the automated
docking of each monosaccharide. Each
run of AUTODOCK3.05 generated 100
different docking options, and only
those that juxtaposed within the an-
tibody paratope were selected. All
docking options from a run of
AUTODOCK3.05 are colored similarly
and shown in the context of the CDR loops of their respective antibody structures. The different structures of each antibody generated during the simulation are
superimposed with respect to the framework regions to depict variation, if any, in the CDR loops.
Conformational Flexibility and Molecular Mimicry 1373
Biophysical Journal 94(4) 1367–1376
site. The presence of additional binding sites may explain the
ability of the antibody to recognize diverse sugars. To test
this, we analyzed the binding of methyl-a-D-glucopyrano-
side, which had been shown to bind to mAb 2D10 with
equivalent affinity and with significantly lower affinity to
mAb 1H7 (12). Consistent with experimental data, the
average docking energy for both mannopyranoside and
glucopyranoside are similar in the case of 2D10, whereas for
mAb 1H7 it is considerably higher for glucopyranoside than
for mannopyranoside (Table 3). Additionally, whereas
glucopyranoside binds at a single site, overlapping with the
proposed common monosaccharide binding site within the
1H7 paratope, it can dock at multiple sites that overlap with
the mannopyranoside binding sites within the 2D10 paratope
(Fig. 5 B).
DISCUSSION
The vast recognition repertoire of the immune system while
maintaining exquisite specificity of the response against any
invading antigen is, indeed, remarkable. Breakdown in this
specificity, however, manifests as molecular mimicry. We at-
tempted to delineate the mechanisms of binding of indepen-
dent yet mimicking antigens to anti-carbohydrate antibodies
that differed in their recognition potential; whereas mAb 1H7
was specific to the immunizing mannopyranoside alone, mAb
2D10 could recognize 12-mer peptide in addition to the
carbohydrate moiety. The kinetic and thermodynamic stud-
ies have indicated the role of paratope conformational flex-
ibility in the binding of antigens that mimic one another
(12). In addition to deciphering the structural features of the
paratope critical for mimotope recognition, our studies dem-
onstrate diversity in antigen binding modes and interactions.
The crystal structure of 1H7 Fab revealed no significant
dissimilarity in antigen-combining sites of the two molecules
in the asymmetric unit, indicating structural invariance in the
antibody paratope. Despite differences in the packing envi-
ronments of the two molecules, the RMSD of the Ca atoms
of the six CDR loops was not substantial, and most side
chains were in a similar orientation. Interestingly, the aro-
matic side chain of the antibody heavy-chain Tyr-106 over-
laps with the common monosaccharide binding site. We
defined this common site based on comparative analysis of
the structures of various anti-carbohydrate antibodies in com-
plex with their respective saccharide antigens. It was there-
fore reasonable to expect that such an orientation of the
heavy-chain Tyr-106 residue, stabilized by interactions both
within the paratope and due to crystal packing, sterically ob-
structs the binding of mannopyranoside. This probably resulted
in the crystallization of 1H7 Fab in the unliganded state even
though cocrystallization was set up with 25 molar excess of
mannopyranoside. Comparison of the structural features of
the antigen-combining sites of mAbs 2D10 and 1H7 showed
that the CDR loops of the two antibodies belong to the same
class of canonical structures, with the exception of L1 which
has a five-residue insertion in the case of mAb 2D10.
The importance of topological equivalence between chem-
ically unrelated moieties for functional mimicry has been
suggested (33–35). However, we have demonstrated that func-
tional mimicry can be observed in the context of antibody
response even in the absence of obvious structural correla-
tion between the independent ligands (10,11). Indications of
a possible alternate mode of recognition of mimicking anti-
gens by utilizing conformational flexibility of the ligand bind-
ing site arose from our kinetic and thermodynamic analyses
(12). MD simulation provides an elegant window to observe
the structural dynamics of a range of possible conformations
inherent in the protein molecule. MD simulations at different
temperatures revealed significantly greater variation in the
RMSD of the Ca atoms of the CDR loops, importantly in
CDR H3, in the case of mimicry-recognizing antibody 2D10
vis a` vis the immunogen-specific mAb 1H7. Indeed, the
structural investigations reported in this study substantiate
the premise that mAb 2D10 exhibits conformational flexi-
bility in the antigen-combining site. On the other hand, the
antibody 1H7 shows relatively low structural mobility in the
paratope.
The structural basis of the conformational fluctuations in
the loops of 2D10 as against 1H7 was analyzed. While ad-
dressing the cause for the differential binding potential of the
two antibodies, we had previously analyzed the differences
in the nature of the residues lining the antigen-combining site
of the antibodies (12). We could not, however, attribute any
significant difference in the nature of residues of the paratope
to differences in their recognition repertoire despite CDR L1
of 2D10 having a five-residue insertion as compared to 1H7.
This analysis based on MD simulations demonstrated that
the conformational variability within the antigen binding site
of 2D10 is contributed by both CDR L1, which has a five-
residue insertion in the case of 2D10, and CDR H3, which
has a physiologically critical role in defining specificity. In-
terestingly, there are three times as many intramolecular
hydrogen bonds within the antigen-combining site of mAb
1H7 as compared to mAb 2D10.
The correlation of the structural features of the antibody
paratope with differential modes of antigen binding was es-
tablished by analyzing the nature of the interactions involved.
It was pertinent to discern whether the conformational flex-
ibility demonstrated by the simulation studies might be
TABLE 3 Average estimated docking energy for
monosaccharides binding to anti-mannopyranoside antibodies
Average docking energy (kcal/mol)
1H7 2D10
Mannopyranoside 6.9 (60.3) 7.1 (60.6)
Glucopyranoside 5.7 (60.3) 6.8 (60.3)
Of the 100 different options of either monosaccharide docked onto different
structures of mAbs 1H7 and 2D10 output every 50 ps during the 500 ps
MD simulation, the lowest docking energies were averaged. Values in
parentheses represent the standard deviation.
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reflected in the recognition repertoire of these antibodies.
Automated docking of mannopyranoside, based on the energy
of the interactions between the ligand and the receptor, should
reveal all the potential carbohydrate binding sites within the
antibody paratope. Consistent with expectations, upon altering
the side-chain orientation of HTyr-106 (BTyr-106), which
was hindering ligand access, mannopyranoside could snugly
dock in the antibody 1H7 paratope. This docking site over-
laps with the proposed common primary monosaccharide
binding site present in other anti-sugar antibodies in complex
with oligosaccharides.
The automated docking onto mAb 2D10 revealed that
mannopyranoside could bind at additional sites besides the
common primary monosaccharide binding site. The existence
of multiple binding modes within the antibody paratope ap-
pears to be a direct outcome of the conformational adopt-
ability of the antibody. The presence of multiple conformational
states in dynamic equilibrium may expose buried surfaces
that act as potential/additional binding sites for the carbo-
hydrate antigen. The binding of other sugars like glucopy-
ranoside at the common monosaccharide binding site, albeit
with lower affinity, in the case of mAb 1H7 and multiple equiv-
alent binding modes for mAb 2D10 supports our inferences
regarding the ability of the mimicry-recognizing antibody to
bind two independent antigens utilizing the intrinsic flexibility
in the antigen-combining site.
It has been proposed that affinity maturation involves the
evolution of the antibody paratope to reduce its inherent
flexibility and toward epitope complementarity, resulting in
a well-defined binding site for the immunogen in mature
antibodies (36,37). However, our studies demonstrate that an
immune response generated in the context of molecular mim-
icry includes not only antibodies like 1H7, which have nar-
row specificity, but also those like mAb 2D10, which possess
paratope conformational flexibility and facilitate recognition
of mimotopes despite an imperfect topological relationship.
Physiologically, this may be important; when pathogens evade
immune surveillance by changing their antigenic determi-
nants, the immune system needs to recognize altered antigens
despite their structural differences. Responses under such
conditions therefore may include antibody receptors with
broader recognition specificities. A certain proportion of sec-
ondary antibodies that possess conformational flexibility, ex-
emplified by mAb 2D10, are probably designed to disregard
antigenic variation. At the same time, antibodies like mAb
1H7 that have acquired the ability to discriminate ensure high
specificity of the mature immune response. Thus, our studies
reflect the diversity in the immune response at the structural
level, even against small immunogens such as mannopyrano-
side. The antibodies not only show sequence variation due to
independent germ line origins and differences in their ther-
modynamic characteristics of antigen binding, but also ex-
hibit diversity in terms of the structural properties of the
paratope which is reflected as multiple antigen recognition
modes.
In summary, we suggest that alternate mechanisms of en-
hancement of the recognition repertoire exist in the mature
immune response that manifest as molecular mimicry even in
the absence of well-defined structural similarity. Our inves-
tigations of the mechanisms by which the immune system
addresses molecular equivalences suggest that fidelity of
recognition of the response is maintained by antibodies that
have a rigid and predesigned binding site for the immunizing
antigen, and the antibodies which possess paratope confor-
mational flexibility ensure a sufficiently large repertoire of
specificities. Thus, the receptor-specificmodulations ofmolec-
ular mimicry perhaps reflect strategies evolved by the adaptive
immune system to counter the changing surface properties of
invading pathogens.
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